N Saijo

Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell Lines

Kazuo Kasahara, Yasuhiro Fujiwara, Y. Sugimoto et al. · JNCI Journal of the National Cancer Institute · 1992 · 86 citations

Medicine, Oncology, Pharmacology +15

Prospective Evaluation of the Feasibility of Cisplatin‐based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions

Fumihiro Oshita, Takayasu Kurata, Takashi Kasai et al. · Japanese Journal of Cancer Research · 1995 · 81 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell Line

Yasuhiro Fujiwara, Yoshikazu Sugimoto, Kazuo Kasahara et al. · Japanese Journal of Cancer Research · 1990 · 74 citations · Full text

Medicine, Oncology, Pharmacology +13

A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)

Shunichi Negoro, Kazumasa Noda, Yutaka Nishiwaki et al. · Lung Cancer · 2000 · 71 citations

Medicine, Oncology, Pharmacology +9

Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.

T Morikage, Tohru Ohmori, Kazuto Nishio et al. · PubMed · 1993 · 66 citations

Medicine, Oncology, Pharmacology +14